Search Results

There are 651 results for: content related to: Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed, cisplatin for locally advanced esophageal squamous cell carcinoma

  1. Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways

    Molecular Carcinogenesis

    Volume 52, Issue 3, March 2013, Pages: 183–194, Tsung-Ying Yang, Gee-Chen Chang, Kun-Chieh Chen, Hsiao-Wen Hung, Kuo-Hsuan Hsu, Chi-Hao Wu, Gwo-Tarng Sheu and Shih-Lan Hsu

    Version of Record online : 15 NOV 2011, DOI: 10.1002/mc.21842

  2. You have full text access to this Open Access content
    Significance of thymidylate synthase for resistance to pemetrexed in lung cancer

    Cancer Science

    Volume 101, Issue 1, January 2010, Pages: 161–166, Hiroaki Ozasa, Tetsuya Oguri, Takehiro Uemura, Mikinori Miyazaki, Ken Maeno, Shigeki Sato and Ryuzo Ueda

    Version of Record online : 10 SEP 2009, DOI: 10.1111/j.1349-7006.2009.01358.x

  3. You have free access to this content
    Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non–small cell lung cancer


    Volume 121, Issue 6, March 15, 2015, Pages: 883–892, Robert C. Doebele, David Spigel, Mustapha Tehfe, Sachdev Thomas, Martin Reck, Sunil Verma, Janice Eakle, Frederique Bustin, Jerome Goldschmidt Jr, Dachuang Cao, Ekaterine Alexandris, Sergey Yurasov, D. Ross Camidge and Philip Bonomi

    Version of Record online : 6 NOV 2014, DOI: 10.1002/cncr.29132

  4. You have free access to this content
    Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer


    Volume 118, Issue 19, 1 October 2012, Pages: 4694–4705, Susan Urba, Carla M. L. van Herpen, Tarini Prasad Sahoo, Dong M. Shin, Lisa Licitra, Klara Mezei, Christoph Reuter, Ricardo Hitt, Francesca Russo, Shao-Chun Chang, Anwar M. Hossain, Bente Frimodt-Moller, Andrew Koustenis and Ruey-Long Hong

    Version of Record online : 20 MAR 2012, DOI: 10.1002/cncr.27449

  5. You have full text access to this Open Access content
    Cytotoxic effects of pemetrexed in gastric cancer cells

    Cancer Science

    Volume 96, Issue 6, June 2005, Pages: 365–371, Jee Hyun Kim, Keun-Wook Lee, Yeonjoo Jung, Tai Young Kim, Hye Seon Ham, Hyun-Soon Jong, Kyung Hae Jung, Seock-Ah Im, Tae-You Kim, Noe Kyeong Kim and Yung-Jue Bang

    Version of Record online : 15 JUN 2005, DOI: 10.1111/j.1349-7006.2005.00058.x

  6. You have free access to this content
    Review of a promising new agent—pemetrexed disodium


    Volume 97, Issue S8, 15 April 2003, Pages: 2056–2063, Luis Paz-Ares, Susana Bezares, José M. Tabernero, Daniel Castellanos and Hernán Cortes-Funes

    Version of Record online : 1 APR 2003, DOI: 10.1002/cncr.11279

  7. You have full text access to this Open Access content
    Tumor response and clinical toxicity associated with second-line chemotherapy regimens for advanced non-squamous non-small cell lung cancer: A retrospective cohort study

    Thoracic Cancer

    Volume 5, Issue 5, September 2014, Pages: 365–376, Chengping Hu, Yan Wang, Jianhua Chen, Shengqi Wu, Xiaoling Li, Yuqin Wang, Yicheng Yang, Narayan Rajan, Manny Papadimitropoulos, Qiong Xiao, Huan Zhan and Wendong Chen

    Version of Record online : 25 AUG 2014, DOI: 10.1111/1759-7714.12102

  8. You have free access to this content
    Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study


    Volume 119, Issue 15, 1 August 2013, Pages: 2754–2764, Athanasios Karampeazis, Alexandra Voutsina, John Souglakos, Nikos Kentepozidis, Stelios Giassas, Charalambos Christofillakis, Athanasios Kotsakis, Pavlos Papakotoulas, Ageliki Rapti, Maria Agelidou, Sofia Agelaki, Lambros Vamvakas, George Samonis, Dimitris Mavroudis and Vassilis Georgoulias

    Version of Record online : 9 MAY 2013, DOI: 10.1002/cncr.28132

  9. You have free access to this content
    A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer


    Volume 117, Issue 4, 15 February 2011, Pages: 795–801, Matthew G. Fury, Sofia Haque, Hilda Stambuk, Ronglai Shen, Diane Carlson and David Pfister

    Version of Record online : 4 OCT 2010, DOI: 10.1002/cncr.25464

  10. Prediction of Neutropenia-Related Effects of a New Combination Therapy With the Anticancer Drugs BI 2536 (a Plk1 Inhibitor) and Pemetrexed

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 5, November 2010, Pages: 660–667, E Soto, A Staab, M Freiwald, G Munzert, H Fritsch, C Döge and I F Trocóniz

    Version of Record online : 6 OCT 2010, DOI: 10.1038/clpt.2010.148

  11. You have free access to this content
    Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01)


    Volume 118, Issue 24, 15 December 2012, Pages: 6234–6242, Jong-Mu Sun, Ki Hyeong Lee, Sang-we Kim, Dae Ho Lee, Young Joo Min, Hwan Jung Yun, Hoon Kyo Kim, Hong Suk Song, Yeul Hong Kim, Bong-Seog Kim, In Gyu Hwang, Keehyun Lee, Sook Jung Jo, Jae Won Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn and for the Korean Cancer Study Group (KCSG)

    Version of Record online : 6 JUN 2012, DOI: 10.1002/cncr.27630

  12. Water-soluble poly(ethylene glycol) prodrug of pemetrexed: Synthesis, characterization, and preliminary cytotoxicity

    Journal of Applied Polymer Science

    Volume 111, Issue 1, 5 January 2009, Pages: 444–451, Tao Min, Hai Ye, Peng Zhang, Jun Liu, Can Zhang, Wenbin Shen, Wan Wang and Longsheng Shen

    Version of Record online : 3 OCT 2008, DOI: 10.1002/app.29047

  13. You have free access to this content
    SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma

    International Journal of Cancer

    Volume 132, Issue 2, 15 January 2013, Pages: 459–471, Kota Iwahori, Satoshi Serada, Minoru Fujimoto, Barry Ripley, Shintaro Nomura, Hiroyuki Mizuguchi, Kazuki Shimada, Tsuyoshi Takahashi, Ichiro Kawase, Tadamitsu Kishimoto and Tetsuji Naka

    Version of Record online : 17 MAY 2012, DOI: 10.1002/ijc.27611

  14. Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck cancer: Results of an exploratory subgroup analysis of a phase III trial

    Asia-Pacific Journal of Clinical Oncology

    Volume 9, Issue 4, December 2013, Pages: 331–341, Susan Urba, Ruey-Long Hong, Anwar M Hossain, Rebecca Cheng and Mauro Orlando

    Version of Record online : 26 FEB 2013, DOI: 10.1111/ajco.12060

  15. Audit of patients with mesothelioma treated with pemetrexed in a single institution in Western Australia

    Asia-Pacific Journal of Clinical Oncology

    Volume 6, Issue 4, December 2010, Pages: 350–356, Arman HASANI, Kynan FEENEY, Anna NOWAK and Michael MILLWARD

    Version of Record online : 27 JUL 2010, DOI: 10.1111/j.1743-7563.2010.01316.x

  16. Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma

    Intervention Review

    The Cochrane Library

    John A Green, Yenal Dundar, Susanna R Dodd, Rumona C Dickson and Tom Walley

    Published Online : 24 JAN 2007, DOI: 10.1002/14651858.CD005574.pub2

  17. You have free access to this content
    Cost-Effectiveness of Pemetrexed Plus Cisplatin: Malignant Pleural Mesothelioma Treatment in UK Clinical Practice

    Value in Health

    Volume 11, Issue 1, January/February 2008, Pages: 4–12, Anna Cordony, Corinne Le Reun, Antje Smala, James T. Symanowski and Jessamy Watkins

    Version of Record online : 25 JUN 2007, DOI: 10.1111/j.1524-4733.2007.00209.x

  18. You have free access to this content
    Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma


    Volume 92, Issue 3, 1 August 2001, Pages: 595–600, Frances A. Shepherd, Janet Dancey, Andrew Arnold, Alan Neville, James Rusthoven, Robert D. Johnson, Bryn Fisher and Elizabeth Eisenhauer

    Version of Record online : 9 AUG 2001, DOI: 10.1002/1097-0142(20010801)92:3<595::AID-CNCR1359>3.0.CO;2-D

  19. You have free access to this content
    The pemetrexed/gemcitabine combination in pancreatic cancer


    Volume 95, Issue S4, 15 August 2002, Pages: 928–932, Hedy Lee Kindler

    Version of Record online : 19 JUL 2002, DOI: 10.1002/cncr.10755

  20. You have free access to this content
    Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer


    Volume 104, Issue 11, 1 December 2005, Pages: 2449–2456, Ralph G. Zinner, Frank V. Fossella, Gregory W. Gladish, Bonnie S. Glisson, George R. Blumenschein Jr., Vassiliki A. Papadimitrakopoulou, Katherine M.W. Pisters, Edward S. Kim, Yun W. Oh, Beverly O. Peeples, Zhishen Ye, Rafael E. Curiel, Coleman K. Obasaju, Waun K. Hong and Roy S. Herbst

    Version of Record online : 28 OCT 2005, DOI: 10.1002/cncr.21480